Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
ACRES Commercial Realty Corp. (ACR)
NYSEReal EstateReit - MortgageSnapshot 2026-11-04
$13.11-8.06%
Close 2026-11-05 · 1-day change
NYSEReal EstateReit - MortgageSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.67 → 1.67 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ACR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS near -$0.02 in 2026 | A primary condition in ACRES Commercial Realty Corp.'s published investment case. The stated target is >= -$0.02. | Broken | EPS falls below -$0.05 in FY26 | Diluted EPS: $-1.87 per share FY2026-Q2; GAAP. Published target: >= -$0.02. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 2026-1.87 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
ACR is a higher-risk, rate-sensitive real estate investment with fragile earnings quality and volatile management execution. Its long-term thesis is currently intact, supported by recent performance holding in the top half of its industry and completion of the ACRES merger, but confidence has eased to medium.
ACR is described as cheap versus peers, while the model also indicates a 0.69 premium versus peers, so the valuation picture is mixed. The expectations gap is negative at -0.53, and the evidence says fragility is low because weak execution quality alone is not paired with the full expensive, weak, and turbulent combination.
Near term, earnings risk is elevated, with a 0.78 estimated chance of a miss after consecutive recent misses. Revenue rose from $17.8 million in 2026-Q1 to $20.98 million in 2026-Q2, and management has delivered the ACRES merger, but targeted EAD yields have not yet been explicitly reported. Debt issuance and the termination of a material agreement are recent events, while active debt management and buybacks remain part of capital allocation.
The multi-year view depends partly on whether ACR achieves its stated post-transaction EAD yield target of 8% to 15% and maintains disciplined capital allocation. Near term, a guidance cut or continued earnings misses would weaken the setup; Fed rate cuts could support rate-sensitive real estate, while cracks at sector peers could remove that support.
Over the next 1 to 3 years, ACR’s thesis has some support from merger completion and recent revenue growth, but it remains fragile and exposed to execution and sector risks. The valuation signals are mixed, and near-term earnings delivery is the key test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| ACRES plans to merge with ACRES Capital Corp. |
| Recovered |
| Merger not completed by end 2026 |
Merger completed News shows capital allocation and M&A activity but no merger termination or delay. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 3 supplied quarters. Management reported: “"In the third quarter, ACRES completed the merger transaction with its manager and is now internally managed.” “Going forward the Company will have three lines of business that management expects to drive results in the future: Principal Investing, Investment Management and Insurance," said ACRES Commercial Realty Corp. Chairman Andrew Fentress.” Delivery assessment Nov 4, 2026 |
Post-transaction EAD yields between 8% and 15% | Management targets yields between 8% and 15%. | Intact | Yields fall below 8% after merger | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches about $2 billion in 2026 | Revenue guidance is about $2 billion for 2026. | Intact | Revenue falls below $1.9 billion in FY26 | Revenue: $20.98M FY2026-Q2; GAAP. Published target: ~$2 billion. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 202620,980,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.44 → $1.67 · observed estimates
$0.08B → $0.07B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.44 | $75,321,500 | 1 / 1 |
| 2026-07-25 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-07-26 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-07-27 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-07-28 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-07-29 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-07-30 | $1.44 | $75,321,500 | 1 / 1 |
| 2026-07-31 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-08-01 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-08-02 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-08-03 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-08-04 | $0.78 | $84,200,000 | 1 / 1 |
| 2026-08-05 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-06 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-07 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-08 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-09 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-10 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-11 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-12 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-13 | $1.23 | $75,730,000 | 2 / 2 |
| 2026-08-14 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-15 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-16 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-17 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-18 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-19 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-20 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-21 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-22 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-23 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-24 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-25 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-26 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-27 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-28 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-29 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-30 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-08-31 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-09-01 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-09-02 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-09-03 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-09-04 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-09-05 | $1.23 | $75,730,000 | 1 / 1 |
| 2026-09-06 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-07 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-08 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-09 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-10 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-11 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-12 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-13 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-14 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-15 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-16 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-17 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-18 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-19 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-20 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-21 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-22 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-23 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-24 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-25 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-26 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-27 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-28 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-29 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-09-30 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-01 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-02 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-03 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-04 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-05 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-06 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-07 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-08 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-09 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-10 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-11 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-12 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-13 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-14 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-15 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-16 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-17 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-18 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-19 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-20 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-21 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-22 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-23 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-24 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-25 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-26 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-27 | $1.67 | $67,260,000 | 1 / 1 |
| 2026-10-28 | $1.67 | $67,260,000 | 2 / 1 |
| 2026-10-29 | $1.67 | $67,260,000 | 2 / 1 |
| 2026-10-30 | $1.67 | $67,260,000 | 2 / 1 |
| 2026-10-31 | $1.67 | $67,260,000 | 2 / 1 |
| 2026-11-01 | $1.67 | $67,260,000 | 2 / 1 |
| 2026-11-02 | $1.67 | $67,260,000 | 2 / 1 |
| 2026-11-03 | $1.67 | $67,260,000 | 2 / 1 |
| 2026-11-04 | $1.67 | $67,260,000 | 2 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.